New rules mean 3.6 million Americans could get Wegovy via Medicare, costing billions
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.
Apr 24, 2024
0
3
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF analysis says.
Apr 24, 2024
0
3
Prior to February 2024, limited therapeutics were available to treat sepsis, a life threatening organ dysfunction caused by a dysregulated host response to infection. Now, a new, commercially viable method of treatment is ...
Apr 13, 2024
0
1
New research questions the effectiveness of the U.S. Food and Drug Administration's accelerated drug approval program after finding that many cancer drugs remain unproven five years later.
Apr 8, 2024
0
2
Christian Espinoza, director of a Southern California drug-treatment provider, recently began employing a powerful new assistant: an artificial intelligence algorithm that can perform eye exams with pictures taken by a retinal ...
Apr 5, 2024
0
0
A Louisville, Colorado, company is studying whether cells taken from patients' fat could reduce knee pain and improve motion in people with arthritis.
Mar 27, 2024
0
8